These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2868105)

  • 1. Indirect dopaminergic effects of tofisopam, a 2,3-benzodiazepine, and their inhibition by lithium.
    Chopin P; Stenger A; Couzinier JP; Briley M
    J Pharm Pharmacol; 1985 Dec; 37(12):917-9. PubMed ID: 2868105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacologic effects of tofizopam (Grandaxin)].
    Petócz L
    Acta Pharm Hung; 1993 Mar; 63(2):79-82. PubMed ID: 8100112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is tofisopam an atypical anxiolytic?
    Pellow S; File SE
    Neurosci Biobehav Rev; 1986; 10(2):221-7. PubMed ID: 2874535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new sensitive method which unlike the Vogel test detects the anxiolytic effect of tofisopam.
    Miklya I; Knoll J
    Pol J Pharmacol Pharm; 1988; 40(6):561-72. PubMed ID: 2908362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioural effects of thieno and pyrazolo [2,1] benzothiazepine derivatives in mice.
    Expósito-Orta MA; Albertos LM; Darias V; Sánchez-Mateo CC
    Arzneimittelforschung; 2004; 54(7):365-70. PubMed ID: 15344839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tofisopam and midazolam: differences in clinical effects and in changes of CSF monoamine metabolites.
    Hovi-Viander M; Kanto J; Scheinin H; Scheinin M
    Br J Clin Pharmacol; 1985 Nov; 20(5):492-6. PubMed ID: 2416331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naloxone-blocked depriming effect of anxiolytic selank on apomorphine-induced behavioral manifestations of hyperfunction of dopamine system.
    Meshavkin VK; Kost NV; Sokolov OY; Zolotarev YA; Myasoedov NF; Zozulya AA
    Bull Exp Biol Med; 2006 Nov; 142(5):598-600. PubMed ID: 17415472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of amineptine with agents modifying dopaminergic transmission.
    Chagraoui A; Vasse M; Protais P
    Clin Neuropharmacol; 1989; 12 Suppl 2():S19-31. PubMed ID: 2576526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychopharmacological effects of tianeptine analogous hetero[2,1] benzothiazepine derivatives.
    Sánchez-Mateo CC; Darias V; Albertos LM; Expósito-Orta MA
    Arzneimittelforschung; 2003; 53(1):12-20. PubMed ID: 12608009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The behavioural and neuronal effects of the chronic administration of benzodiazepine anxiolytic and hypnotic drugs.
    Hutchinson MA; Smith PF; Darlington CL
    Prog Neurobiol; 1996 May; 49(1):73-97. PubMed ID: 8817699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropharmacology of a new psychotropic 2,3-benzodiazepine.
    Andrási F; Horváth K; Sineger E; Berzsenyi P; Borsy J; Kenessey A; Tarr M; Láng T; Kórösi J; Hámori T
    Arzneimittelforschung; 1987 Oct; 37(10):1119-24. PubMed ID: 2893623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proceedings: Behavioral effects of direct and indirect acting dopaminergic agonists.
    Moore KE
    Psychopharmacol Bull; 1974 Jul; 10(3):41-2. PubMed ID: 4419323
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic variations in midbrain dopamine cell number: parallel with differences in responses to dopaminergic agonists and in naturalistic behaviors mediated by central dopaminergic systems.
    Fink JS; Reis DJ
    Brain Res; 1981 Oct; 222(2):335-49. PubMed ID: 6116521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines.
    Crawley JN
    Pharmacol Biochem Behav; 1981 Nov; 15(5):695-9. PubMed ID: 6118883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant-like effect of tofisopam in mice: A behavioural, molecular docking and MD simulation study.
    Turan Yücel N; Evren AE; Kandemir Ü; Can ÖD
    J Psychopharmacol; 2022 Jul; 36(7):819-835. PubMed ID: 35638175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticonvulsant, anxiolytic, and non-sedating actions of imidazenil and other imidazo-benzodiazepine carboxamide derivatives.
    Auta J; Kadriu B; Giusti P; Costa E; Guidotti A
    Pharmacol Biochem Behav; 2010 Jun; 95(4):383-9. PubMed ID: 20227434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tofisopam, a new 2,3-benzodiazepine. Inhibition of changes induced by stress loading and hypothalamic stimulation.
    Yamaguchi K; Suzuki K; Niho T; Shimora M; Ito C; Ohnishi H
    Can J Physiol Pharmacol; 1983 Jun; 61(6):619-25. PubMed ID: 6136319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cannabinoid CB1 receptor is involved in the anxiolytic, sedative and amnesic actions of benzodiazepines.
    García-Gutiérrez MS; Manzanares J
    J Psychopharmacol; 2010 May; 24(5):757-65. PubMed ID: 19825899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lithium on behaviour and central monoamines.
    Engel J; Berggren U
    Acta Psychiatr Scand Suppl; 1980; 280():133-43. PubMed ID: 6773300
    [No Abstract]   [Full Text] [Related]  

  • 20. Dopaminergic--GABA-ergic interaction in the nigrostriatal system.
    Koltai MZ; György L
    Acta Physiol Acad Sci Hung; 1981; 58(3):225-33. PubMed ID: 7348023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.